Could 'open innovation' models that have proved successful in other sectors be fruitfully adopted by the pharmaceutical industry? In the past, the business model adopted by most high-tech ...

According to IMS Health, in 2009 the pharmaceutical market in China increased by 27.9% to reach $31.7 billion and by 2013 — partly because of the effects of both health-care and drug safety ...